Abstract:OBJECTIVE:To investigate the relationship between serum C-reactive protein (CRP) and metabolic disorders in individuals in Shanghai communities and to assess the value of CRP level on the risk of metabolic disorders.METHODS:A total of 5502 individuals (males 2379, females 3123) aged over 20 years with complete baseline data on metabolic syndrome (MS) and serum CRP from 1998 to 2001 in two communities of Shanghai were included. Highly sensitive CRP was tested by kinetics nephelometry. Quartiles of concentration of CRP were computed. Hyperglycemia (diabetes or impaired glucose regulation), hypertension, dyslipidemia, central obesity and MS were defined by WHO (1999) working definition of MS. Logistic regression model was used to estimate the relation between CRP level and relative risks of metabolic disorders.RESULTS:(1) In this two communities based population the prevalences of metabolic syndrome and its components were as follow: hyperglycemia 21.63% (diabetes 9.21%, impaired glucose regulation 12.41%), hypertension 32.95%, high triglyceride (TG)/low high-density lipoprotein cholesterol (HDL-C) 46.04%, central obesity 40.68% and metabolic syndrome 13.98%. (2) Serum CRP level was gradually elevated with the increment of ages in both men and women (P < 0.01). (3) Serum CRP level was increased with the increment of the components of metabolic disorders (P < 0.01). In individuals with MS, CRP level was higher than in those with 1 or 2 components of metabolic disorders (P < 0.01). (4) The highest quartile of CRP was 2.11 mg/L in men and 2.22 mg/L in women. (5) Compared with those in the lowest quartile, men in the highest quartile had increased relative risk of hyperglycemia (3.8 times), central obesity (5.5 times), hypertension (2.8 times), hyper triglyceride (1.3 times), low HDL-C (1.5 times) and MS (10 times). Similarly, women in the highest quartile had increased relative risk of hyperglycemia (7.7 times), central obesity (12.2 times), hypertension (6.1 times), hypertriglyceride (5.6 times), low HDL-C (1.1 times) and MS (8.5 times).CONCLUSION:(1) CRP level was related to the increment of age. (2) Individuals with more components of metabolic syndrome had higher serum CRP level. (3) The incidence of metabolic syndrome was increased with the increment of CRP level. The risk of metabolic disorders including hyperglycemia, hypertension, dyslipidemia, central obesity and metabolic syndrome was significantly elevated in men with CRP level over 2.11 mg/L and women with CRP level over 2.22 mg/L.

The Association of Macroangiopathy with Levels of PAI-1 and C-reactive Protein and Cerebro-Cardiovascular Risk Factors in Metabolic Syndrome

Changes of Matrix Metalloproteinase -3 and Urokinase -Type Plasminogen Activator Receptor in Type 2 Diabetes Mellitus with Macroangiopathy

Relationship Between the Prothrombotic State and Leukoaraiosis in Elderly Patients with Metabolic Syndrome

The Changes of Secretory Type Ⅱ Phospholipase A2 in Coronary Heart Disease and Its Relationship with High Sensifive-C Reactive Protein

Association of Serum Phospholipid Fatty Acid and High-Sensitivity C Reactive Protein in Patients with Metabolic Syndrome and Type 2 Diabetes Mellitus

Relationship between carotid intima-media thickness and metabolic markers in patients with essential hypertension

Analysis of the correlation of sEPCR, hs-CRP, TNF-α and IL-18 levels with macroangiopathy in type 2 diabetes mellitus patients

The Significance and Risk Factor Analysis of Homocysteine in Diabetic Patients with Macroangiopathy

Measure serum metalloproteinase matrix-9 and tissue inhibitor of metalloproteinase-1 in the patients with type 2 diabetic macroangiopathy

Relationship Between Blood Level of Homocysteine and Macroangiopathy in Patients With Type 2 Diabetes Mellitus

High-Sensitivity C-Reactive Protein Predicts Target Organ Damage in Chinese Patients with Metabolic Syndrome

ASSOCIATION OF INSULIN RESISTANCE AND C-REACTIVE PROTEIN WITH CORONARY ARTERY DISEASE IN PATIENTS WITH NORMAL GLUCOSE TOLERANCE

[Study on the Associations Between Inflammatory Factor and Insulin Resistance As Well As Type 2 Diabetes with Macrovascular Complications].

Correlation of carotid artery atherosclerosis with C-reactive protein and adiponectin in patient with metabolic syndrome

Study on the relationship between high-sensitivity C-reactive protein and carotid atherosclerosis in the patients with metabolic syndrome

Relationship between C-reactive protein level and angiographical characteristics of coronary atherosclerosis

Analysis of Correlated Factors Influencing Macroangiopathy in Patients with New Onset Type 2 Diabetes Mellitus

[Association Between C-reactive Protein Level and Metabolic Syndrome and Components Thereof].

Lipoprotein(a), high-sensitivity C-reactive protein, and cardiovascular risk in patients undergoing percutaneous coronary intervention

Mac-1 Alongside Platelet-Monocyte Aggregates as Potential Markers in Acute Coronary Syndrome: A Case-Control Study

Blood PAI-1 and cardiovascular and metabolic risk factors among the middle-aged women from SWAN study